Thomas Pincez: Estimating the Effect of Fetal Hemoglobin on Sickle Cell Trait Using Polygenic Scores
Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood RCI, adding:
“Fetal hemoglobin (HbF) is a major modifier of sickle cell disease.
Even small changes in HbF levels driven by common variants can affect sickle cell disease outcomes.
But what about sickle cell trait? Studying HbF effect on sickle cell trait complications is challenging, as HbF is not routinely measured.
To overcome this obstacle, we leveraged polygenic scores to estimate HbF levels in two cohorts.
We consistently found no association between HbF levels and the main complications of sickle cell trait: chronic kidney disease and venous thromboembolism.
These results suggest that common variations affecting HbF levels are not significant modifiers of sickle cell trait outcomes in the majority of individuals.
However, we have not investigated the potential impact of rare genetic mutations that cause extremely high HbF levels.”
Title: Estimating the effect of fetal hemoglobin on sickle cell trait using polygenic scores
Authors: Elias Hanna, Estelle Lecluze, Elisha Chacowry, Guillaume Lettre, Manon Saby, Thomas Pincez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias
-
Sep 17, 2026, 14:51Konstantin Yenkoyan: Emicizumab and the Power of Translational Science